Australia markets closed

Fresh Tracks Therapeutics, Inc. (FRTX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.9003-0.0097 (-1.07%)
At close: 01:53PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
8,006
8,006
6,943
404
1,822
Operating expenses
Research development
3,182
3,182
14,043
28,231
11,216
Selling general and administrative
11,184
11,184
14,434
12,417
11,582
Total operating expenses
14,366
14,366
28,477
40,648
22,798
Operating income or loss
-6,360
-6,360
-21,534
-40,244
-20,976
Interest expense
5
5
9
69
0
Total other income/expenses net
671
671
441
839
63
Income before tax
-5,694
-5,694
-21,102
-39,474
-20,913
Income from continuing operations
-5,694
-5,694
-21,102
-39,474
-20,913
Net income
-5,694
-5,694
-21,102
-39,474
-20,913
Net income available to common shareholders
-5,694
-5,694
-21,102
-39,474
-20,913
Basic EPS
-2.32
-
-7.51
-22.12
-38.25
Diluted EPS
-2.32
-
-7.51
-22.12
-38.25
Basic average shares
4,654
-
2,808
1,785
544.759
Diluted average shares
4,654
-
2,808
1,785
544.759